From discovery to manufacturing: revolutionizing biopharma workflows with Oxford Nanopore sequencing
Date: Thursday, Oct 9, 2025
Time: 10:00 am–04:00 pm EDT (Registration opens at 09:00 am)
Location: Crowne Plaza Philadelphia - King of Prussia
Free of charge
Agenda to follow
This focused one-day event will showcase how Oxford Nanopore Technologies is transforming the biopharma industry with dedicated presentations on QC and R&D, and real-world insights from industry experts.
Learn how experts are utilizing Oxford Nanopore sequencing to enhance biopharma workflows—and connect directly with Oxford Nanopore specialists to explore solutions tailored to your needs.
For inquiries regarding this event, please contact: events@nanoporetech.com
Speakers
)
Welcome
Brett Fritz, Oxford Nanopore Technologies
...
)
Biopharma strategy at Oxford Nanopore
Veronica Fowler, PhD, Oxford Nanopore Technologies
Veronica Fowler is Director of Market Development (Biopharma Solutions) at Oxford Nanopore Technolog...
)
Accelerating Pfizer’s biotherapeutic production pipeline
Hamza Sahil, Pfizer, Inc
Hamza Sahil leads the DNA production and NGS efforts at Pfizer-Cambridge in the Biotherapeutic Expre...
)
mRNA analytical challenges and NGS based solutions
Glenn Milton, PhD, Moderna Tx
B.S. from Quinnipiac University in 2010. Ph.D. from University of Connecticut in Molecular and Cellu...
)
Optimizing QC testing of mRNA vaccines and therapeutics
Amanda Hughes, Lonza Netherlands B.V.
To follow...
)
The future of Oxford Nanopore
Lakmal Jayasinghe, Oxford Nanopore Technologies
Dr Lakmal Jayasinghe is the Chief Scientific Officer at Oxford Nanopore Technologies, where he leads...
)
From plasmids to genomes: powering discovery with Oxford Nanopore Technologies
Max Bangs, PhD, GENEWIZ by Azenta Life Sciences
Max Bangs is a Technical Applicant Scientist at GENEWIZ, where he specializes in the development and...
)
From data to decisions: EPI2ME analysis for biopharma quality control
Dr. Matt Parker, Oxford Nanopore Technologies
Dr. Matt Parker is Director, Clinical Bioinformatics Software at Oxford Nanopore Technologies and si...
Agenda
09:00 am–04:00 pm PDT | Topic | Speaker |
|---|---|---|
09:00 am–10:00 am | Registration/Check In/Breakfast | |
10:00 am–10:05 am | Welcome | Brett Fritz, Oxford Nanopore Technologies |
10:05 am–10:30 am | Biopharma strategy at Oxford Nanopore | Veronica Fowler, PhD, Oxford Nanopore Technologies |
10:30am–11:00 am | Accelerating Pfizer’s biotherapeutic production pipeline | Hamza Sahil, Pfizer Inc |
11:00 am–11:30 am | Networking Break | |
11:30 am–12:00 pm | mRNA analytical challenges and NGS based solutions | Glenn Milton, PhD, Moderna Tx |
12:00 pm–12:30 pm | Optimizing QC testing of mRNA vaccines and therapeutics | Amanda Hughes, Lonza Netherlands B.V |
12:30 pm–01:30 pm | Lunch | |
01:30 pm–02:00 pm | Future of Oxford Nanopore | Lakmal Jayasinghe, Oxford Nanopore Technologies |
02:00 pm–02:30 pm | From plasmids to genomes: powering discovery with Oxford Nanopore Technologies | Max Bangs, PhD, GENEWIZ by Azenta Life Sciences |
02:30 pm–03:00 pm | From data to decisions: EPI2ME analysis for biopharma quality control | Matt Parker, PhD, Oxford Nanopore Technologies |
03:00 pm–04:00 pm | Networking Cocktail Reception |
